Michael Mæng says: “Patients with coronary heart disease have a substantial risk of recurrent events such as myocardial infarction, stroke, and premature death. This increased risk is present despite optimal treatment. The aim of our project is to examine the interplay between this increased risk of recurrent events and the presence of prediabetes, diabetes, and novel cholesterol lipoproteins using a large cohort based primarily on the Western Denmark Heart Registry with long-term follow-up and dedicated intravascular imaging of coronary atherosclerosis. We want to: 1) estimate the risk associated with having prediabetes, 2) to examine why diabetes is associated with a two-fold risk of myocardial infarction, and 3) to examine how novel cholesterol lipoproteins in the blood influences a) cholesterol content in the coronary plaques and b) the following risk of myocardial infarction.”
Michael Mæng is senior consultant at the Department of Cardiology, Aarhus University Hospital, and associate professor at Aarhus University since 2016.